Abstract
3D Slicer is an open-source software platform for the analysis, segmentation, and three-dimensional visualization of medical imaging data. Although the platform is used by an international research community, its interface was historically available primarily in English, which may limit accessibility for non-English-speaking users. This study describes the development of an ad hoc methodology for the Brazilian Portuguese localization of 3D Slicer within the broader Latin American localization initiative. The methodology addresses recurrent linguistic challenges identified in a preliminary corpus of 300 interface strings, including domain-specific vocabulary, acronyms, word order, passive voice, syntagms, and the adaptation of technical terms. The translation process emphasizes textual uniformity, cohesion, terminological accuracy, and contextual validation in biomedical-computational environments. The proposed framework may support similar software localization efforts in other non-English-speaking contexts, especially when technical precision and linguistic adaptation must be balanced.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This article was partly made possible by grants number 2021-237549 and 2022-252572 from the Chan Zuckerberg Initiative DAF, an advised Silicon Valley Community Foundation fund.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Footnotes
This revised version improves the manuscript title, methodological description, references, data availability statement, discussion, conclusion, figures, and bibliography. The Materials and methods section now clarifies the exploratory and problem-oriented 300-string corpus, the Brazilian Portuguese translation workflow, glossary use, and contextual validation of interface strings. References to Slicer for Latin America, public localization resources, and the Brazilian Portuguese glossary were corrected and expanded. The figures were redesigned for improved legibility. The study object and central conclusions remain unchanged.
Data Availability
All data produced are available online at www.slicer.org
